🇺🇸 Renacidin in United States

FDA authorised Renacidin on 22 June 1982

Marketing authorisations

FDA — authorised 22 June 1982

  • Application: NDA018519
  • Marketing authorisation holder: BAXTER HLTHCARE
  • Local brand name: IRRIGATING SOLUTION G IN PLASTIC CONTAINER
  • Indication: SOLUTION — IRRIGATION
  • Status: approved

Read official source →

FDA — authorised 22 June 1982

  • Marketing authorisation holder: BAXTER HLTHCARE
  • Status: approved

FDA — authorised 15 March 1984

  • Application: NDA018904
  • Marketing authorisation holder: HOSPIRA
  • Local brand name: UROLOGIC G IN PLASTIC CONTAINER
  • Indication: SOLUTION — IRRIGATION
  • Status: approved

Read official source →

FDA — authorised 2 October 1990

  • Application: NDA019481
  • Marketing authorisation holder: UNITED GUARDIAN
  • Local brand name: RENACIDIN
  • Indication: SOLUTION — IRRIGATION
  • Status: approved

Read official source →

FDA — authorised 17 December 2002

  • Application: NDA021314
  • Marketing authorisation holder: MERIDIAN BIOSCIENCE
  • Indication: Type 3 - New Dosage Form
  • Status: approved

Read official source →

FDA — authorised 28 November 2017

  • Application: NDA209589
  • Marketing authorisation holder: FERRING PHARMS INC
  • Indication: Type 3 - New Dosage Form
  • Status: approved

Read official source →

FDA — authorised 22 May 2020

  • Application: NDA208352
  • Marketing authorisation holder: EVOFEM INC
  • Indication: Type 3 - New Dosage Form and Type 4 - New Combination
  • Status: approved

Read official source →

FDA

  • Application: ANDA205743
  • Marketing authorisation holder: PAR PHARM INC
  • Local brand name: CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE
  • Indication: FOR SOLUTION — ORAL
  • Status: approved

Read official source →

Renacidin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in United States

Frequently asked questions

Is Renacidin approved in United States?

Yes. FDA authorised it on 22 June 1982; FDA authorised it on 22 June 1982; FDA authorised it on 15 March 1984.

Who is the marketing authorisation holder for Renacidin in United States?

BAXTER HLTHCARE holds the US marketing authorisation.